#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Bronchopulmonary dysplasia Idiopathic intracranial hypertension Renal cell carcinoma Colitis ulcerative Advanced systemic mastocytosis Primary mediastinal large B-cell lymphoma Duchenne muscular dystrophy Immunodeficiency congenital Li-Fraumeni syndrome Canavan disease Raynaud's phenomenon Ornithine transcarbamoylase deficiency Ureteric cancer Intracranial calcification Sexually transmitted disease More trials…

    Learn about Rare Diseases

    Haemophagocytic lymphohistiocytosis – Treatment Sjogren’s syndrome – Treatment Shprintzen-Goldberg syndrome – Treatment Cytokine release syndrome – Treatment Lennox-Gastaut syndrome – Basic Information Hereditary angioedema with C1 esterase inhibitor deficiency Alport’s syndrome – Treatment Medulloblastoma – Basic Information Glomerulonephritis membranous – Life with Disease KBG syndrome – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Taldefgrobep Alfa Lactose Monohydrate Glutenin Talquetamab Quavonlimab Reboxetine Caspofungin Acetate Nitrogen LINAPRAZAN GLURATE ATIGOTATUG Calcitriol DCC-3084 Ketotifen Hydrogen Fumarate Epirubicin Hydrochloride Bimekizumab Eftilagimod Alfa VG801-1 AZD0292 Trabectedin Gsk3858279 More therapies…

    Learn about Your Condition

    Uterine leiomyoma Angiosarcoma Insulin resistance Breast cancer Mechanical ventilation Cortical dysplasia Diarrhoea Breast cancer in situ Breast angiosarcoma Primary hypercholesterolaemia Pleomorphic leiomyosarcoma Knee arthroplasty Urethral valves Angiopathy Endometrial stromal sarcoma More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Uncategorized

  • Study on the Effect of Clozapine and Drug Combination for Patients with Schizophrenia Experiencing First-Line Treatment Failure

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Amisulpride
    • Brexpiprazole
    • Cariprazine
    Austria Germany Italy Spain

  • Study on Colchicine for Patients with Angina Symptoms and Coronary Microvascular Disease

    Recruiting

    2 1 1
    Investigated Diseases:
    • Myocardial ischaemia
    • Acute myocardial infarction
    Investigated Drugs:
    • Regadenoson
    • Adenosine
    • Colchicine
    Denmark

  • Study on Venetoclax and Drug Combination for Adults with Newly Diagnosed Acute Myeloid Leukemia or Myelodysplastic Syndrome with Excess Blasts-2

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Acute myeloid leukaemia
    Investigated Drugs:
    • Cytarabine
    • Daunorubicin
    • Venetoclax
    Austria Belgium Estonia Finland Germany Lithuania +2

  • Study of Oral Vancomycin for Adults and Young Adults with Primary Sclerosing Cholangitis

    Recruiting

    2 1 1
    Investigated Diseases:
    • Cholangitis sclerosing
    Investigated Drugs:
    • Vancomycin
    Italy

  • Study on Reducing Tacrolimus in Kidney Transplant Patients with Low Immunological Risk Using Tacrolimus, Mycophenolic Acid, and Prednisone

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Renal transplant
    Investigated Drugs:
    • Iohexol
    • Prednisolone Metasulfobenzoate Sodium
    • Mycophenolate Mofetil
    France Norway Spain

  • Study on the Safety and Effectiveness of Quizartinib for Children with Newly Diagnosed FLT3-ITD Positive AML and Normal NPM1

    Recruiting

    2 1 1
    Investigated Diseases:
    • Acute myeloid leukaemia
    Investigated Drugs:
    • Quizartinib Dihydrochloride
    Belgium Denmark Estonia Finland Iceland Latvia +6
Previous Page
1 … 560 561 562 563 564 … 1,654
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!